Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.61 |
| ▸ | LMNA | P02545 | 6/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | UQCRB | P14927 | 2/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TYR | P14679 | 1/20 | 0.48 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27721989 | 0.98 | ALDH1A1 (0.59) | ALDH1A1LMNAGAATSHRUQCRB | |
| Hydrochloric Acid SCHEMBL1326865 | 0.98 | ALDH1A1 (0.59) | ALDH1A1LMNAGAATSHRUQCRB | |
| SCHEMBL25384264 | 0.94 | ALDH1A1 (0.55) | ALDH1A1LMNAGAATSHRUQCRB | |
| SCHEMBL2950033 | 0.94 | ALDH1A1 (0.55) | ALDH1A1LMNAGAATSHRUQCRB | |
| Ammonia Solution, Strong SCHEMBL25386856 | 0.92 | ALDH1A1 (0.53) | ALDH1A1LMNAGAATSHRUQCRB | |
| SCHEMBL16563158 | 0.90 | ALDH1A1 (0.52) | ALDH1A1LMNAGAATSHRUQCRB | |
| SCHEMBL28852092 | 0.90 | ALDH1A1 (0.52) | ALDH1A1LMNAGAATSHRUQCRB | |
| SCHEMBL16563244 | 0.90 | ALDH1A1 (0.53) | ALDH1A1LMNAGAATSHRUQCRB | |
| SCHEMBL25385943 | 0.88 | ALDH1A1 (0.50) | ALDH1A1LMNAGAATSHRUQCRB | |
| SCHEMBL16563156 | 0.88 | ALDH1A1 (0.50) | ALDH1A1LMNAGAATSHRUQCRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 662 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3790985-B1 | METHODS OF SYNTHESIZING A POLYNUCLEOTIDE ARRAY USING PHOTACTIVATED AGENTS | VIBRANT HOLDINGS LLC (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260034124-A1 | NOVEL SALTS AND CRYSTALS | INTRA CELLULAR THERAPIES INC (US) | 2026-02-05 | — | — | US | claimed |
| EP-4561569-A2 | NOVEL SALTS AND CRYSTALS | Intra-Cellular Therapies, Inc. (US) | 2025-06-04 | — | — | EP | claimed |
| WO-2025086496-A1 | LITHIUM SUPPLEMENT AND PREPARATION METHOD THEREFOR, POSITIVE ELECTRODE SHEET, BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2025-05-01 | — | — | WO | claimed |
| CN-118813329-A | Diamond wire cutting fluid and preparation method thereof | 东莞市希尔金属材料有限公司 | 2024-10-22 | — | — | CN | claimed |
| WO-2024110994-A1 | A PROCESS FOR THE PREPARATION OF LEDIPASVIR | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2024-05-30 | — | — | WO | claimed |
| CN-116253623-B | Direct cross-coupling method of aryl fluorine sulfate and aryl bromine | 南京工业大学 | 2024-04-05 | — | — | CN | claimed |
| CN-117776955-A | Synthetic method of mugwort Fu Nibu and intermediate thereof | 苏州莱安医药化学技术有限公司 | 2024-03-29 | — | — | CN | claimed |
| WO-2024030835-A2 | NOVEL SALTS AND CRYSTALS | INTRA-CELLULAR THERAPIES, INC. (US) | 2024-02-08 | — | — | WO | claimed |
| CN-116376599-A | Efficient and environment-friendly scale inhibitor for ethylene device gasoline stripping tower and preparation method thereof | 上海良田化工有限公司 | 2023-07-04 | — | — | CN | claimed |
| EP-2374779-A1 | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors | Bayer Pharma Aktiengesellschaft (DE) | 2011-10-12 | — | — | EP | claimed |
| US-20110200535-A1 | DAA-PYRIDINE AS PERIPHERAL BENZODIAZEPINE RECEPTOR LIGAND FOR DIAGNOSTIC IMAGING AND PHARMACEUTICAL TREATMENT | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-08-18 | — | — | US | claimed |
| CN-101065445-B | Thermosetting resin composition, thermosetting-resin molding material, and cured object obtained therefrom | SUMITOMO BAKELITE CO | 2011-05-11 | — | — | CN | claimed |
| US-20100233086-A1 | COMPOUNDS FOR USE IN IMAGING, DIAGNOSING AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2010-09-16 | — | — | US | claimed |
| US-20090191129-A1 | COMPOUNDS FOR USE IN IMAGING, DIAGNOSING AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS | Lantheus Biosciences Ltd. (GB) | 2009-07-30 | — | — | US | claimed |
| US-7541410-B2 | Thermosetting resin composition, thermosetting resin molding compound and cured product thereof | SUMITOMO BAKELITE CO., LTD. (JP) | 2009-06-02 | — | — | US | claimed |
| EP-2053033-A1 | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors | Bayer Schering Pharma AG (DE) | 2009-04-29 | — | — | EP | claimed |
| US-20080139757-A1 | Thermosetting Resin Composition, Thermosetting Resin Molding Compound And Cured Product Thereof | SUMITOMO BAKELITE CO., LTD. (JP) | 2008-06-12 | — | — | US | claimed |
| US-4368130-A | Process of preparing grease composition | PHILLIPS PETROLEUM COMPANY (US) | 1983-01-11 | — | — | US | claimed |
| US-4261840-A | Grease composition and preparation thereof | PHILLIPS PETROLEUM COMPANY (US) | 1981-04-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034124-A1 | NOVEL SALTS AND CRYSTALS | SLC6A4, SLC6A3, HTR2A | ALDH1A1 1599/4885LMNA 2615/4885GAA 1946/4885 |
| US-20110200535-A1 | DAA-PYRIDINE AS PERIPHERAL BENZODIAZEPINE RECEPTOR LIGAND FOR DIAGNOSTIC IMAGING AND PHARMACEUTICAL TREATMENT | GABRA6, GABRA4, GABRA1 | ALDH1A1 798/4885LMNA 2748/4885GAA 1166/4885 |
| US-20090191129-A1 | COMPOUNDS FOR USE IN IMAGING, DIAGNOSING AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS | PMP22, MEN1, VHL | ALDH1A1 2741/4885LMNA 1871/4885GAA 571/4885 |
| US-20100233086-A1 | COMPOUNDS FOR USE IN IMAGING, DIAGNOSING AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS | PMP22, MEN1, VHL | ALDH1A1 2741/4885LMNA 1871/4885GAA 571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.